Oncodesign
FranceWho owns Oncodesign?
Oncodesign is a French Biotech company, currently owned by Eurazeo since 2022 and 3 other investors.
Hand-verified · updated 2026-04-21
Open JSON · CC-BY
Key facts
- ·Co-held by Crédit Mutuel Equity, Eurazeo, Elyan Partners and Edmond de Rothschild Private Equity (France) since 2008.
- ·4 distinct PE sponsors across ownership cycles.
Ownership history
4 ownership periods · co-invest detected
More from Edmond de Rothschild Equity Strategies IV
Other portfolio companies in the same fund.
Switzerland
USMore PE-backed in Biotech
Comparable biotech deals from other GPs.
Questions
Who owns Oncodesign?
Oncodesign is currently owned by Eurazeo, Elyan Partners and 2 others, through Edmond de Rothschild Equity Strategies IV, since 2022.
When did Eurazeo and 3 others acquire Oncodesign?
Eurazeo and 3 others acquired Oncodesign in 2022.
Who has owned Oncodesign over time?
Oncodesign has been through 4 private-equity ownership periods: Crédit Mutuel Equity · via Crédit Mutuel Equity · since 2008; Eurazeo · via Nov Sante Actions Non Cotees · since 2022; Elyan Partners · via ERES IV · since 2022; Edmond de Rothschild Private Equity (France) · via Edmond de Rothschild Equity Strategies IV · since 2022.